全文获取类型
收费全文 | 246126篇 |
免费 | 19192篇 |
国内免费 | 2909篇 |
专业分类
耳鼻咽喉 | 2597篇 |
儿科学 | 6085篇 |
妇产科学 | 4677篇 |
基础医学 | 30898篇 |
口腔科学 | 5212篇 |
临床医学 | 24576篇 |
内科学 | 49123篇 |
皮肤病学 | 3269篇 |
神经病学 | 21846篇 |
特种医学 | 8429篇 |
外国民族医学 | 20篇 |
外科学 | 36119篇 |
综合类 | 10571篇 |
现状与发展 | 13篇 |
一般理论 | 293篇 |
预防医学 | 22305篇 |
眼科学 | 5013篇 |
药学 | 18796篇 |
35篇 | |
中国医学 | 3062篇 |
肿瘤学 | 15288篇 |
出版年
2023年 | 1186篇 |
2022年 | 1534篇 |
2021年 | 5148篇 |
2020年 | 3419篇 |
2019年 | 4481篇 |
2018年 | 5115篇 |
2017年 | 4412篇 |
2016年 | 4566篇 |
2015年 | 5848篇 |
2014年 | 8282篇 |
2013年 | 11273篇 |
2012年 | 16487篇 |
2011年 | 17948篇 |
2010年 | 10736篇 |
2009年 | 9430篇 |
2008年 | 16061篇 |
2007年 | 16857篇 |
2006年 | 16056篇 |
2005年 | 16251篇 |
2004年 | 15244篇 |
2003年 | 14304篇 |
2002年 | 13613篇 |
2001年 | 2762篇 |
2000年 | 2119篇 |
1999年 | 2469篇 |
1998年 | 3070篇 |
1997年 | 2645篇 |
1996年 | 2358篇 |
1995年 | 2088篇 |
1994年 | 1873篇 |
1993年 | 1727篇 |
1992年 | 1293篇 |
1991年 | 1216篇 |
1990年 | 1084篇 |
1989年 | 975篇 |
1988年 | 1010篇 |
1987年 | 1017篇 |
1986年 | 995篇 |
1985年 | 1072篇 |
1984年 | 1442篇 |
1983年 | 1429篇 |
1982年 | 1771篇 |
1981年 | 1606篇 |
1980年 | 1519篇 |
1979年 | 797篇 |
1978年 | 929篇 |
1977年 | 904篇 |
1976年 | 811篇 |
1975年 | 662篇 |
1974年 | 654篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
61.
62.
63.
Evaluation of training nurses to perform semi‐automated three‐dimensional left ventricular ejection fraction using a customised workstation‐based training protocol 下载免费PDF全文
64.
Sharisse M. Arnold Rehring Liza M. Reifler Jennifer H. Seidel Karen A. Glenn John F. Steiner 《Academic pediatrics》2019,19(5):572-580
ObjectiveClinical specialty societies recommend long-acting reversible contraceptives (LARCs) as first-line contraception for adolescent women. We evaluated whether a combined educational and process improvement intervention enhanced LARC placement in primary care within an integrated health care system.MethodsThe intervention included journal clubs, live continuing education, point-of-care guidelines, and new patient materials. We conducted a retrospective cohort study across 3 time periods: baseline (January 2013?September 2015), early implementation (October 2015–March 2016), and full implementation (April 2016–June 2017). The primary outcome was the proportion of LARCs placed by primary care clinicians among women aged 13 to 18 years compared with gynecology clinicians.ResultsKaiser Foundation Health Plan of Colorado cared for approximately 20,000 women aged 13 to 18 years in each calendar quarter between 2013 and 2017. Overall, LARC placement increased from 7.0 per 1000 members per quarter at baseline to 13.0 per 1000 during the full intervention. Primary care clinicians placed 6.2% of all LARCs in 2013, increasing to 32.1% by 2017 (P < .001), including 45.5% of contraceptive implants. Clinicians who attended educational sessions were more likely to adopt LARCs than those who did not (17.9% vs 6.4% respectively, P = .009). Neither overall LARC placement rates (relative risk, 1.9; 95% confidence interval, 0.7?5.6) nor contraceptive implant rates (relative risk, 3.0; 95% confidence interval, 0.9?9.8) increased significantly in clinicians who attended educational activities.ConclusionsThis multimodal intervention was associated with increased LARC placement for adolescent women in primary care. The combination of education and process improvement is a promising strategy to promote clinician behavior change. 相似文献
65.
66.
Bryan Mclaughlin JungHwan Yang Woohyun Yoo Bret Shaw Soo Yun Kim Dhavan Shah 《Health communication》2016,31(6):762-771
The growth of online support groups has led to an expression effects paradigm within the health communication literature. Although religious support expression is characterized as a typical subdimension of emotional support, we argue that in the context of a life-threatening illness, the inclusion of a religious component creates a unique communication process. Using data from an online group for women with breast cancer, we test a theoretical expression effects model. Results demonstrate that for breast cancer patients, religious support expression has distinct effects from general emotional support messages, which highlights the need to further theorize expression effects along these lines. 相似文献
67.
John Lennon Silva Cunha Amanda Almeida Leite Thamiris de Castro Abrantes Lorena Passoni Vervloet Thayn Melo de Lima Morais Gerson de Oliveira Paiva Neto Tatiana Nayara Librio Kimura Snia Maria Soares Ferreira Ricardo Luiz Cavalcanti de Albuquerque‐Júnior Aline Corrêa Abraho Mario Jos Romaach Bruno Augusto Benevenuto de Andrade Oslei Paes de Almeida Ciro Dantas Soares 《Journal of cutaneous pathology》2021,48(1):24-33
68.
Altan Ahmed John A. Stauffer Jordan D. LeGout Justin Burns Kristopher Croome Ricardo Paz-Fumagalli Gregory Frey Beau Toskich 《Journal of gastrointestinal oncology.》2021,12(2):751
BackgroundNeoadjuvant yttrium-90 transarterial radioembolization (TARE) is increasingly being used as a strategy to facilitate resection of otherwise unresectable tumors due to its ability to generate both tumor response and remnant liver hypertrophy. Perioperative outcomes after the use of neoadjuvant lobar TARE remain underinvestigated.MethodsA single center retrospective review of patients who underwent lobar TARE prior to major hepatectomy for primary or metastatic liver cancer between 2007 and 2018 was conducted. Baseline demographics, radioembolization parameters, pre- and post-radioembolization volumetrics, intra-operative surgical data, adverse events, and post-operative outcomes were analyzed.ResultsTwenty-six patients underwent major hepatectomy after neoadjuvant lobar TARE. The mean age was 58.3 years (17–88 years). 62% of patients (n=16) had primary liver malignancies while the remainder had metastatic disease. Liver resection included right hepatectomy or trisegmentectomy, left or extended left hepatectomy, and sectorectomy/segmentectomy in 77% (n=20), 8% (n=2), and 15% (n=4) of patients, respectively. The mean length of stay was 8.3 days (range, 3–33 days) and there were no grade IV morbidities or 90-day mortalities. The incidence of post hepatectomy liver failure (PHLF) was 3.8% (n=1). The median time to progression after resection was 4.5 months (range, 3.3–10 months). Twenty-three percent (n=6) of patients had no recurrence. The median survival was 28.9 months (range, 16.9–46.8 months) from major hepatectomy and 37.6 months (range, 25.2–53.1 months) from TARE.ConclusionsMajor hepatectomy after neoadjuvant lobar radioembolization is safe with a low incidence of PHLF. 相似文献
69.
70.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217